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The prevalence of unintended pregnancy among women receiving medication assisted 
treatment (MAT) for opioid use disorder (OUD) exceeds 80%. While much of the existing 
literature has focused on the consequences of substance use in pregnancy, few have focused on 
the prevention of unintended pregnancy. This study explored barriers and facilitating factors 
impacting contraception use among women, ages 18-45, receiving MAT for OUD in Middle 
Tennessee.  
A cross-sectional survey design was used to describe the women’s sociodemographic and 
health characteristics; report their knowledge, attitudes, and behaviors; and to assess if these 
variables are associated with current use of contraception. Among survey respondents (N=262; 
response rate of 98%), most women were publicly insured (92%), sexually active in the past year 
(88.2%), pregnant at least once in their lifetime (97%), and most had experienced at least one 
unintended pregnancy (83.6%). Although 60.7% agreed it was important to avoid pregnancy, all 
contraception groups had low levels of contraception knowledge.  
Consistent voluntary use of reliable contraception, like long-acting reversible 
contraception (LARC), can reduce the risk of unintended pregnancy among women with OUD. 
Improvement strategies are warranted to ensure women enrolled in MAT for OUD have access 
to reliable contraception methods and noncoercive contraceptive counseling to curb the rising 
rates of unintended pregnancy and reduce rates of neonatal abstinence syndrome (NAS). 
Integrating reproductive health services into MAT programs may support the woman’s 
commitment to sustained recovery by promoting continuity of care and reproductive autonomy 
while being cognizant of historical trauma and current disparities. 
Keywords: contraception, opioid use disorder, substance use disorder, and addiction.
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Introduction and Background 
While the maternal and fetal impact of drug use in pregnancy has received substantial 
research attention, few studies have specifically evaluated the high rates of unintended or 
unplanned pregnancy among women of child bearing age with opioid use disorder (OUD) 
(Terplan, Hand, Hutchinson, Salisbury-Afshar, & Heil, 2015). Among women with opioid use 
disorder (OUD), current literature suggests that unplanned pregnancy rates have been estimated 
at 8 to 9 out of every 10 pregnancies, a ten-fold increase when compared to the general 
population (Black & Day, 2016; Drescher-Burke, 2014; Guttmacher Institute, 2019; Heil et al., 
2011; Robinowitz et al., 2016; Wellings et al., 2013). Without publicly funded programs 
designed to help millions of women avoid unintended pregnancies, the rates of unintended 
pregnancy would be much higher (Guttmacher Institute, 2019).  
Irregular patterns of contraception use, complicated by social determinants of health, 
poor access to and utilization of women’s health services, infrequent sexual activity, and 
insufficient knowledge on the various contraceptive methods and their associated side effects 
have been identified as reasons for the elevated rates of unintended pregnancy among women 
with OUD (Black et al., 2012). Given contraceptive use is a vital component in controlling 
unplanned or unintended pregnancy, it is important to understand the factors and conditions that 
drive the use of contraceptives among opioid addicted women of childbearing age (Centers for 
Disease Control and Prevention, 2015).  
In 2018, the state of Tennessee implemented several strategies to combat the growing 
complexity of opioid abuse and unintended pregnancy in Tennessee. An action plan was 
warranted in 2000 after the number of fetus’ exposed to opioids in Tennessee rose from 0.7 to 
5.1 per 1,000 births; a rate nearly three times the national average (Erwin, Lindley, Meschke, & 
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Ehrlich, 2017; Miller et al., 2017; Patrick et al., 2015). One strategy pertinent to this scholarly 
project is to remove barriers for voluntary long-acting reversible contraceptives (LARC) for 
women with opioid use disorder as a means to avoid unplanned pregnancy among women with 
OUD (TennCare, 2018). However, the barriers and facilitating factors that drive contraception 
use among women with OUD have not yet been fully studied. Therefore, this study sought to 
identify and describe the barriers and facilitators impacting contraception use among women of 
child-bearing age receiving MAT in Middle Tennessee. 
Review of Evidence 
Sociodemographic Risk Factors 
The highest unintentional pregnancy rates are documented among women who are young, 
low-income, publicly insured, cohabitating, of minority descent, and without high school 
degrees. These socio-demographic characteristics coincide with those of women with an OUD 
who experience particularly high rates of unintended pregnancy (Black et al., 2012; Matusiewicz 
et al., 2017). In contrast, the lowest unintended pregnancy rates are among women of higher 
incomes, white, married, and college graduates (Black & Day, 2016; Guttmacher Institute, 2019; 
Hanson, Northwehr, Yang, & Romitti, 2015; Heil et al., 2011; Matusiewicz, Melbostad, & Heil, 
2017; Wellings et al., 2013).  
Socio-demographic factors such as age, ethnicity, insurance, marital status, educational 
attainment, and annual income have been identified as key factors affecting a woman’s ability to 
receive family planning services to prevent unintended pregnancy (Black et al., 2012; Black & 
Day, 2016 Clergue-Duval et al., 2017; Heil, Gaalema, & Herrmann, 2012; Robinowitz et al., 
2016). In 2011, the unintended pregnancy rate among women with an income below the federal 
poverty line was five times greater (112 per 1,000) than those with an income of 200% (20 per 
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1,000) over the poverty line (Finer & Zolna, 2016). Further, rates of unintended pregnancy and 
adverse reproductive health outcomes are highest among low-income minority women 
(American College of Obstetrics and Gynecologists [ACOG], 2015). Because race/ethnicity and 
socioeconomical status (SES) are often correlated in the United States, race/ethnicity was a 
predictor of unintended pregnancies within each racial/ethnic group (Dehlendorf, Ridriguez, 
Levy, Borrero, & Steinauser, 2010; Guttmacher Institute, 2019; Heil et al., 2012; World Health 
Organization [WHO], 2007). 
Low-income women face barriers to contraceptive access due to insurance status. 
Further, lack of insurance is a major risk factor for non-use of prescription contraceptives 
(Dehlendorf et al., 2010; Heil et al., 2012). Some of the most effective contraceptive methods, 
such as an intrauterine device (IUD) or implant, are unfortunately the most expensive, costing an 
individual up to one month’s salary at a minimum-wage job (Guttmacher Institute, 2019; 
Hatcher, Zieman, Allen, Lathrop, & Haddad, 2017). With the expansion of the Affordable Care 
Act, the cost barrier to contraception was nearly eliminated for women covered by either public 
or private insurance. However, women’s awareness of this new access to contraception is unclear 
(Chuang et al., 2015).  
Reliable Contraception Access 
In order for women receiving treatment for substance use disorder to access contraception 
services, a number of barriers must be overcome. These barriers include: inaccurate perception 
that MAT will consistently impair fertility; misinformation or poor knowledge about the 
suitability of different birth control methods; difficulty using conventional healthcare systems; 
mistrust of health care services; fear of forced treatment; guilt, denial, or embarrassment 
regarding their substance use; stigma; and expense (Armstrong et al. 1999; Black et al., 2012; 
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Black & Day, 2016; Heil et al., 2011; Heil et al., 2012; Howell & Chasnoff, 1999; Morse, 
Ramesh, Jackson, 2017; Terplan et al., 2015; Wellings et al., 2013). As a result, contraception 
use among women with SUDs is markedly lower than the general population, which may be 
attributed to barriers faced by the woman seeking services or attributed to reproductive health 
topics not being addressed when care is sought (Armstrong et al., 1999; Black & Day, 2016, 
Clergue-Duval et al., 2017; MacAfee, Harfmann, Kolenic, & Dalton, 2017; Terplan et al., 2015). 
Integrating reproductive health services into treatment programs may be an effective intervention 
for women at risk for unplanned pregnancy (Black et al, 2012; Frost, Lindberg, & Finer, 2012; 
Guttmacher Institute, 2019; Terplan et al., 2015).  
Substance abuse treatment programs which provide a range of services to meet the needs 
of complex patients are more appealing and acceptable to the patients (Olsen, Banwell, & 
Madden, 2014). Since women in substance abuse treatment programs are in regular contact with 
a health care provider, incorporating family planning services into their treatment is reasonable 
(Terplan et al., 2015). Consistently, women are highly interested in integrating family planning 
services into their substance abuse treatment programs, as it is a familiar environment many 
perceive to be less threatening since they are typically being treated by a known and trusted 
provider (Black et al, 2012; Black & Day, 2016; Heil et al., 2012; MacAfee et al., 2017; 
Robinowitz et al. 2016). If reproductive health services are offered in conjunction with SUD 
treatment, not only may the risk of unplanned pregnancies and substance-exposed pregnancies be 
reduced, but it may also improve the quality of life for the women in treatment programs (Black 
& Day, 2016; Heil et al., 2011; Heil et al., 2012; Robinowitz et al.,2016; Terplan et al., 2015). 
By increasing women’s knowledge of various contraceptive methods and reducing the financial 
barrier to access, studies report women are more likely to choose a significantly more reliable 
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method of contraception such as a LARC (Black & Day, 2016; Secura, Allsworth, Madden, 
Mullersman, & Peipert, 2010). 
Accurate Contraception Knowledge 
In previous research, a significant knowledge gap was discovered when assessing 
contraception knowledge, attitudes, and beliefs among women receiving MAT. Numerous 
misconceptions, inaccuracies, and areas of uncertainty about various birth control methods and 
their side effects impact a woman’s choice to use contraception (Robinowitz et al., 2016). 
Reported misconceptions included: menstrual irregularities; weight gain; miscarriage; 
fearmongering; low pregnancy risk related to MAT; falsified significant adverse effects; and 
ineffectiveness (Black et al., 2012; Robinowitz et al., 2016). These misconceptions or false 
beliefs may be the result of insufficient knowledge about various contraceptive methods (Black 
et al., 2012; Black & Day, 2016; Frost et al., 2012; Robinowitz et al., 2016).  
Individuals’ knowledge of various contraception methods, benefits, and potential side 
effects is often based on personal experience or information learned from others, not information 
learned from a health care provider (Robinowitz et al., 2016). This is particularly important since 
the efficacy of many forms of birth control heavily relies on the users’ knowledge and 
compliance. Nearly 18% of women at risk of pregnancy who use contraception inconsistently 
and/or incorrectly account for 41% of all unintended pregnancies (Guttmacher Institute, 2019). 
Although user compliance is a significant factor towards birth control efficacy, it is important to 
note two thirds of women in the United States at risk for unintended pregnancy use 
contraceptives consistently and correctly (Guttmacher Institute, 2019). However, these women 
only account for approximately 5% of all unintended pregnancies (Guttmacher Institute, 2019). 
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Although contraceptives are widely used across the world, many women face significant barriers 
accessing contraception to meet their reproductive health needs.  
If family planning services are integrated into substance abuse treatment programs, health 
care providers have the opportunity to educate patients on the various methods and proper use of 
birth control, as well as correct any misconceptions or false beliefs (Black & Day, 2016; Hanson 
et al., 2015; Heil et al., 2011; Morse et al., 2017; Terplan et al., 2015). However, a knowledge 
gap among health care providers can impede their ability to offer accurate information to patients 
inquiring about various contraception methods. Many non-obstetrician-gynecologist clinicians 
have expressed uncertainty about the risks and benefits associated with LARC methods 
(Luchowski et al., 2014). Other barriers to implementation include time constraints, provider 
comfort level in discussing family planning services, and provider beliefs that their focus is to 
solely treat addiction-specific issues (Robinowitz et al., 2016). Despite provider reluctance, 
improved health outcomes, consistent contraception use, and improved maternal mental health 
are well documented when family planning services are integrated into substance abuse 
treatment programs (Black & Day, 2012; Niccols et al., 2010; Robinowitz et al., 2016).  
According to the World Health Organization (WHO) (2007), low investments in health 
services and education slow the societal diffusion of knowledge regarding the use of 
contraception. Therefore, researchers specifically working with women of childbearing age with 
opioid and other substance abuse disorders stressed the importance of practitioners and 
researchers investigating the reasons for using or not using contraception (Black et al., 2012; 
Black & Day, 2016; Heil et al., 2011; Heil et al., 2012; Terplan et al., 2015). Increased insight 
into factors leading to varying patterns of birth control utilization may assist in reduction of 
unintended pregnancies and substance-exposed pregnancies (Hanson et al., 2015). 
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Integrating family planning services with substance abuse treatment markedly reduce 
substance-exposed pregnancies (Black & Day, 2016; Terplan et al., 2015; Robinowitz et al., 
2016). Fetal exposure to opioids occurs when a pregnant woman uses opioids or MAT drugs 
such as methadone or suboxone. However, using MAT drugs such as methadone and suboxone 
to regularize prenatal dosing of opioids helps avoid relapse, and improves compliance with 
prenatal care among women with OUD (ACOG, 2017a; Lee, 2016). Currently, both medications 
are classified as the gold standard treatment option for pregnant women with OUD despite the 
associated risk of neonatal abstinence syndrome (NAS) (ACOG, 2017a). Associated effects of 
MAT use during pregnancy include: NAS, respiratory distress, low birth weight, feeding 
difficulties, sleep disturbances, hyperirritability, and seizures. These complications often result in 
extended inpatient stays to monitor and treat the infant after birth (Lee, 2016; Miller, McDonald, 
& Warren, 2017; Patrick, Davis, Lehman, & Cooper, 2015; Seligman & Berghella, 2018).  
Theoretical Model 
 The theoretical model guiding the scholarly project is the Theoretical Framework of 
Factors Affecting Contraceptive Use and Avoiding Unintended Pregnancy (Kaye, Suellentrop, & 
Beck, 2009) (Figure 1). Developed by the Guttmacher Institute in consultation with the National 
Campaign to Prevent Teen and Unplanned Pregnancy, the model served as a framework in 
constructing The Fog Zone: a national survey focused on the factors surrounding unplanned 
pregnancy by exploring individuals’ knowledge of contraceptives and reproductive health 
behaviors (Kaye et al., 2009). These data produced from The Fog Zone survey enhanced 
researchers’ knowledge of evaluating individuals’ navigation of sexual encounters by 
considering their risk management and evaluation of consequences following an unplanned 
pregnancy (National Center for Family & Marriage Research, 2012).  
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The key constructs of the Theoretical Framework of Factors Affecting Contraceptive Use 
and Avoiding Unintended Pregnancy include: past behavior, demographic variables, exposure to 
contraceptive information, contraception knowledge or misconceptions, beliefs and evaluation of 
consequences, perceived social norms, intention, self-efficacy, and behavior. The framework’s 
constructs mimic the constructs in the Theory of Reasoned Action (TRA) and its extension the 
Theory of Planned Behavior (TPB). Similar to the TRA and TPB, the Theoretical Framework of 
Factors Affecting Contraceptive Use and Avoiding Unintended Pregnancy hypothesizes a 
favorable attitude and subjective norm, in combination with greater perceived control or self-
efficacy, will result in a strong intention to perform a particular behavior (Ajzen, 1991). Figure 1 
provides a visual representation of all direct and/or indirect relationships between constructs and 
the likelihood a specific behavior will occur (Kaye et al., 2009). 
Behavior is reasoned in the sense that intention, social norms and self-efficacy play a 
direct role in determining whether contraception is utilized by an individual (Kaye et al., 2009). 
Intention is a cognitive representation of an individual’s readiness to perform a behavior and is 
considered to be the single best predictor of behavior (Ajzen, 1991; Montano & Kaspryzyk, 
2015). A woman’s intention is directly influenced by the following variables: subjective and 
objective knowledge (knowledge and misconceptions), or beliefs about the likely outcome if 
utilizing birth control and the evaluation of potential outcomes or consequences of not using 
birth control (beliefs and evaluation of consequences); beliefs about the normative expectations 
of family, friends, and their partner regarding birth control use and the motivation to comply 
with these expectations (subjective norms); and beliefs about the presence of facilitators may 
help or hinder using birth control and the perceived power of these factors (self-efficacy) (Ajzen, 
1991; Hanson et al., 2014; Montano & Kaspryzyk, 2015).  
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Personal experience is also suggested as a powerful predictor of behavior. Failure or 
success of past behavioral attempts signals whether the individual believes they can carry out a 
behavior (Yzer, 2012). The power of personal experience is also reflected in past behavior, as it 
encompasses an individual’s history of drug use and their reproductive health history behaviors 
(Kaye et al., 2009). Assessing each person’s past drug use and birth control behaviors provides a 
better understanding of the reproductive health needs of the individual. Further, collectively 
assessing these two behaviors allows for a better understanding of the myriad of effects 
substance abuse can have on a woman’s sexual health including: patterns of contraception, 
irregular menstrual history, sexual abuse, and increased risk of sexually transmitted disease 
(Black et al., 2012). It is possible that a woman’s poor sexual health (behavior) is a result of the 
effects of substance use, social determinants of health (sociodemographic variables), and poor 
access to reproductive health services (exposure to information) (Black et al., 2012; Hanson et 
al., 2014; Kaye et al., 2009). Therefore, evaluating each theoretical construct may produce 
stronger, more nuanced results. 
The Theoretical Framework of Factors Affecting Contraceptive Use and Avoiding 
Unintended Pregnancy framework was used in this scholarly project, as it is a comprehensive 
framework for understanding individuals’ capacities and motivations to avoid unplanned 
pregnancy. Although survey measures were available for all theoretical constructs except 
intention, it was not feasible to assess the entire model (Table 1). For this scholarly project, past 
behavior and the sociodemographic characteristics of the sample were described. Next, 
individuals’ objective and subjective knowledge and attitudes of contraception and their 
evaluation of consequences of using or not using contraception, which theoretically influence the 
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behavior of contraception utilization were explored. The constructs considered are highlighted in 
red in Figure 1.  
Project Design 
A cross-sectional survey design was used for this scholarly project to describe the 
women’s sociodemographic and health characteristics; report their knowledge, attitudes and 
behaviors; and assess if these variables are associated with current use of contraception. This 
study is patterned after an earlier study, performed in Knox County, Tennessee, which also used 
a cross-sectional survey design, was descriptive in format, and addressed the association of birth 
control related knowledge and attitudes with contraception use (Meschke, McNeely, Brown, & 
Prather, 2018). The data used for this scholarly project was collected between September and 
December 2018 at Rapha Centre in Manchester, Tennessee and was deidentified for patient 
protection. The Institutional Review Board of the University of Tennessee, Knoxville approved 
the original study, and project exemption was verified by Belmont University’s Institutional 
Review Board (IRB). 
Clinical Setting 
Primary data was obtained from women, ages 18-45, seeking treatment for opioid 
dependency at the Rapha Centre, located in Coffee County, TN. The Rapha Centre specializes in 
treating patients with opioid-dependency using the following strategies: to provide specific 
mental health therapies unique to the patients’ needs, to closely monitor medical care to promote 
and ensure compliance, to utilize the 12-step recovery tools to overcome addiction, and to 
perform routine drug screenings to improve patient accountability (Rapha Centre, 2018). At 
Rapha Centre, a multi-disciplinary approach is utilized to incorporate both holistic healing and 
MAT therapy using FDA approved drugs containing buprenorphine, naloxone, and/or naltrexone 
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(Rapha Centre, 2018). The Rapha Center team is composed of two physicians, one nurse 
practitioner, eight masters prepared therapists, three nurses, and two medical assistants.  
In 2017, Tennessee had a total of 12 licensed opioid treatment programs designed to 
provide MAT (Sycamore Institute, 2017). However, only 3 of the 12 programs were located 
outside of Nashville (Sycamore Institute, 2017). Rapha Centre currently provides treatment 
services to individuals from 26 counties across Middle Tennessee (Figure 2). Uniquely, they are 
one of the only OUD treatment facilities in Middle Tennessee that accepts TennCare and 
Medicare, in addition to private insurance, for treatment services. To this author’s knowledge, 
the next closest facility also accepting TennCare for outpatient addiction treatment services is 
greater than 100 miles away.  
Project Population 
Currently, approximately 466 patients enrolled at the Rapha Centre, of which, 272 are 
female. For this scholarly project, the study sample consisted of 262 women, ages 18-45 years, 
currently enrolled in Rapha Centre’s MAT program. Convenience sampling method was used for 
patient participation. Recruitment occurred three days per week, from 7:30am to 5:00pm. 
Individuals were eligible to participate in the study if they were (1) female, (2) between 18 and 
45 years of age, (3) were receiving MAT at Rapha Centre from September to December 2018, 
and (4) were willing to participate. All males, women under the age of 18 or over the age of 45, 
and any individual not receiving MAT at Rapha Centre at the time of the study were excluded.  
Sources of Data and Data Collection Instruments 
Survey items utilized in the original study were obtained to maximize comparability 
across populations (Meschke et al., 2018). When possible, the original author compiled survey 
questions from previous studies to create the 58-item survey (Meschke et al., 2018). Permission 
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was obtained to use the 58-item survey for this replication study. Rapha Centre physicians, Dr. 
Rene del Valle and Dr. Carla Lee, reviewed and approved the survey for face and content 
validity. The original survey included measures designed to describe the socio-demographics, 
health status and drug use, reproductive health outcomes and behaviors, and reproductive 
knowledge and attitudes of the female participants (Table 1). Measures requiring calculation or 
coding and other measures used to obtain the above-mentioned measures are described in the 
following sub-sections (Table 2). The complete survey is in Appendix A. 
 Sociodemographic Variables. Sociodemographic variables obtained from the survey 
included the following: age, zip code and county of residence, race/ethnicity, marital status, 
highest level of education, employment status, insurance coverage, household income, number of 
persons living in household, whether the individual has had any difficulty paying rent or utilities 
in the past year, and whether the individual has had to move in with family or friends. Age was 
calculated from birth date and the survey completion date. Race/ethnicity was self-selected by 
the participants from the following races: American Indian/Alaska Native, Asian, Black or 
African American, Hispanic/Latino, Native Hawaiian/Pacific Islander, White, or other. 
Employment status was determined by the following: full time, part time, temporary, 
unemployed – looking for employment, unemployed – not looking for employment, student, 
retired, homemaker, unable to work, or other. These nine employment status options were 
recoded to reflect employed, unemployed, or not in the labor force. All other socio-demographic 
variables utilized in this project are included in Appendix A.  
 Health Status and Drug Use. Health status variables obtained from the survey include: 
general health, depressed mood, date of last normal menstrual cycle, sexual activity, ever having 
nonconsensual sex, ever having been physically abused, ever having experienced physical abuse 
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by romantic partner, or if any children have been in DCS custody. Depressed mood was 
calculated as the mean of four questions adapted from the Center for Epidemiological Studies 
Depression Scale. (α=.68) (Radloff, 1977). Participants reported how often over the past week 
they felt depressed, felt everything they did was an effort, felt hopeful about the future (reverse-
coded), and felt happy (reverse coded; 1 = “rarely or not at all” to 4 = “most of the time”). 
Higher mean scores were indicative of higher levels of depressed mood. 
 Variables assessed in regard to drug use included: duration of MAT treatment, number of 
times each individual had completed intake for treatment services, types of substances used in 
the past, which opioid was used initially, age at first opioid, how the opioid was taken, how they 
obtained the opioid, and whether or not they use cannabis products, cigarettes, smokeless 
tobacco, or e-cigarettes. Years since first opioid was calculated from date of survey, birthdate, 
and age at first opioid use. All other health status and drug use variables utilized in this project 
are included in Appendix A. 
 Reproductive health outcomes and behaviors. Participants were asked about their 
current birth control use, birth control methods used in the past five years, and reasons for not 
using or not scheduling appointments to obtain birth control (e.g. bilateral tubal ligation [BTL]). 
Women were asked to select all methods they were using at the time of survey completion. 
Responses were further categorized into three groups based on their responses to questions asked 
about contraception use: (1) BTL, (2) using contraception, and (3) not using contraception. If 
women selected “none – tubes tied or hysterectomy” for any of the three questions, they were 
categorized in the BTL group. Women who selected “spermicides,” “rhythm method,” 
“douching,” “none – currently trying to get pregnant,” “none - do not wish to get pregnant,” and 
“none – do not use birth control” were categorized as not using contraception. Women were 
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identified as using contraception if they reported current use of the following methods: condoms, 
oral contraceptive pills, the patch, Depo, the NuVa ring, IUD or Mirena, a diaphragm, implant, 
and/or partner had a vasectomy.  
 Women identifying as pregnant were placed into a separate category. A woman was 
classified as having ever been pregnant if she indicated experiencing one or more pregnancies, 
births, miscarriages, or abortions. Total number of pregnancies was calculated as the sum of total 
pregnancies, regardless if the mother ever had a miscarriage, abortion, or if the child was still 
living. The number of unplanned pregnancies was calculated by subtracting the total number of 
planned pregnancies from their total number of pregnancies. All other reproductive health 
variables utilized in this project are included in Appendix A. 
 Reproductive knowledge and attitudes. Reproductive knowledge and attitudes 
variables were assessed through a variety of questions answered using a 5-point scale (1 = 
“strongly disagree” to 5 = “strongly agree”). Knowledge and attitudes of NAS risk among 
participants was measured using a subset of four questions. The author of the original study 
adapted these questions from a study used to evaluate women’s knowledge and attitudes 
regarding alcohol consumption during pregnancy (Meschke et al., 2018; Peadon et al., 2010). 
Higher mean scores were indicative of poor knowledge of NAS. Contraception knowledge was 
measured as the percent of 27 true/false questions answered correctly. A subset of 6 of the 27 
knowledge questions were used to specifically examine participants’ knowledge of LARCs. 
Social support was measured by four questions (α=.68) assessing the woman’s comfort level in 
discussing contraception with their doctor and partner (Ong, Temple-Smith, Wong, McNamee, 
& Fairley, 2012). In addition, women were specifically asked whether or not their partner and 
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friends supported their decision to use contraception. All other reproductive knowledge and 
attitudes variables utilized in this project are included in Appendix A. 
Data Collection Process & Procedures 
All data collection took place three days per week, from September to December 2018. 
The principal investigator invited 266 eligible women to participate in the survey when they 
arrived at the clinic for treatment services using the letter of invitation. Voluntary consent was 
obtained based on acceptance to participate. A total of 262 participants granted consent and 
completed the paper survey while waiting to meet with their therapist and/or while waiting to 
meet with their provider. Completion of all survey measures was typically 15-20 minutes. The 
principal investigator was available to all individuals requesting assistance with completing the 
survey. Participants returned the completed survey to the principal investigator prior to 
conclusion of the treatment visit. Participants completing the survey had the option to be entered 
into a drawing for a $200.00 VISA gift card; the drawing took place on December 12, 2018 at 
Rapha Centre. 
All data collected was coded, transcribed, and stored into Qualtrics by the principal 
investigator. The concise dataset was then exported to IBM SPSS statistical analysis software to 
be analyzed. Extra care was taken in evaluating and calculating missing responses. Because there 
was no discernible pattern of missingness, all 262 cases were used in the analysis in order to 
maintain the robustness of the sample size. In the presentation of descriptive statistics, a category 
for “no response” was included. 
Statistical Analysis 
The Theoretical Framework of Factors Affecting Contraceptive Use and Avoiding 
Unintended Pregnancy framework was used to guide organization and analysis of the survey 
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results. Themes identified in the results were organized using the frameworks constructs 
including: past behavior, socioeconomic and demographic factors, objective and subjective 
knowledge and misconceptions, beliefs and evaluation of consequences, and behavior. 
Identification of such themes to better understand the barriers and facilitating factors of 
contraception use, helped identify potential knowledge gaps and areas of improvement as they 
relate to increasing contraception among the sample population.  
The characteristics of the sample were described using means and standard deviations for 
the continuous measures and frequencies and percentages for the categorical measures. Similar 
to the study by Meschke et al., (2018), chi-square or one-way ANOVA were used to explore 
associations between contraception and pregnancy status or experiences of women, with 
significance determined at p<.05. Bonferroni post hoc tests followed significant chi-squares and 
ANOVA models on variables that were significant in East Tennessee. Given the descriptive 
nature of the study and the sample size of each contraception group, the level of significance was 
not adjusted for multiple comparisons. Adjusting the level of significance and/or conducting 
multiple comparisons could potentially increase the risk of a type II error (Perneger, 1998). 
Further, Bonferroni adjustments are not suggested when assessing evidence about specific 
hypotheses due to the likelihood of committing a Type II error (Perneger, 1998).  
Results 
Sociodemographic Characteristics 
The 262 study participants resided in 26 counties across Middle Tennessee. The top four 
counties represented by women include: Warren (21%; n=55), Coffee (16%; n=42), Rutherford 
(8%; n=21), and White (7.3%; n=19). The mean age of all participants was 32.0 years, with over 
half of the participants being between 26 and 35 years of age (59.7%; n=157). Almost all were 
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white (96%; n=251). Other represented races included African American (3.4%; n=9), American 
Indian/Alaska Native (2.3%; n=6), Hispanic/Latino (1.9%; n=5), and Native Hawaiian/Pacific 
Islander (0.4%; n=1). Over half had an educational attainment level of high school graduate or 
less (55.4%; n=145). One quarter of the participants (27.1%; n=71) had at least some college, 
and 7.9% had either completed an associate degree (n=11), a bachelor’s degree (n=4), or at least 
some graduate level education (n=6). A third of the women (33%; n=87) reported being single 
and most had at least one child at the time of the survey (78.2%; n=205). Sixteen percent (n=43) 
reported losing custody of a child to Department of Children’s Services (DCS) at some point.  
The majority of participants were struggling socioeconomically. Fewer than one third 
(29.4%; n=77) were employed full time and less than a quarter were employed part time or were 
working temporary positions (16.8%; n=44). Among those unemployed, 19.5% (n=51) indicated 
they were seeking work. Two thirds reported an annual household income of $20,000 or less 
(62.2%; n=163). Fewer than one in ten (9.1%; n=24) had household income of $30,000 or more. 
Multiple confounding stressors of poverty accompanying low incomes were reported by two-
thirds (66.4%; n=174) of participants by indicating difficulty paying rent, mortgage, or utilities 
in the past year. Further, over a third (36.3%; n=95) had moved in with friends or family because 
they had no other housing choice.  
Regarding health insurance, the majority of participants were publicly insured by 
TennCare (92%; n=241). Sixteen participants (6.1%) reported having private insurance. Only 
four participants (1.5%) indicated they were uninsured at the time of the survey. Table 3 
provides a full report of the participants’ sociodemographic characteristics.  
Health Status and Substance Use 
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Age of first opioid use ranged from 12 to 40 years. The majority of the women first 
initiated the use of opioids as a late teenager (mean age=19.5). Over half initially accessed 
opioids through a personal prescription (56%; n=147). Other modes of initial access indicated by 
participants included: friend (22.1%; n=58) or family member’s prescription (19.1%; n=50). 
Most (75.6%; n=198) smoked cigarettes daily. A third of women reported using either smokeless 
tobacco products or e-cigarettes (33.3%; n=87), and one in five (20%; n=54) reported regular 
cannabis use. When asked to rate overall health, nearly half of the women self-identified their 
health as good (48.55%; n=127). However, over one third rated their health as poor or fair 
(36.6%; n=96).  
Depression was measured using a four-point depressed mood scale; a score of 4 indicated 
high levels of depressed mood in the past week (See Table 2). The women’s responses ranged 
from 1-4, with an average score of 2.3 — equivalent to selecting “sometimes” or “often” for each 
measure. A depression score of three or greater, indicating high levels of depression, was 
reported by 18% of the women. However, a positive trend was found among the remaining 
responses. In the past week the two-thirds of women reported, “rarely” or “sometimes” feeling 
depressed (n=181; 69.1%), and “rarely” or “sometimes” felt everything they did was an effort 
(n=139; 53.1%). Likewise, half selected either “often” or “most of the time” when asked about 
feeling hopeful for the future (n=147; 56.1%).  A majority selected “often” and “most of the 
time” when describing that they felt happy in the past week (n=161; 61.5%). 
When asked about historical sexual trauma, one third of the women (36.6%; n=96) 
reported having nonconsensual sex. When reflecting on the past year, one quarter (25%; n=66) 
reported experiencing physical abuse from anyone. Nearly one in eight women (12.2%; n=32) 
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reported having been physically abused by her romantic partner in the past year. Table 4 
provides a full report of the participants’ health status and substance use characteristics. 
Reproductive Health Outcomes and Behaviors 
The majority of women indicated they were sexually active in the past year (88.2%; 
n=231). Most women reported having had vaginal sex without a condom in the past two years 
(n=226; 86.3%). Nearly all women reported having been pregnant at least once (97%; n=254), 
and over two thirds reported being pregnant three or more times in their lifetime (67.5%; n=174). 
Approximately one in seven (14.9%; n=39) reported having an abortion at some point in their 
lifetime. Among those who had ever been pregnant, almost half (43.9%; n=115) reported 
experiencing at least one unplanned pregnancy in their lifetime. However, when subtracting the 
number of planned pregnancies from the total number of pregnancies, the percent of unintended 
pregnancies among surveyed women was significantly higher. Through calculation, 83.6% 
(n=219) of the women had experienced at least one unintended pregnancy in their lifetime. The 
total number of pregnancies identified as unplanned ranged from 0-16 (mean = 2.4). More than 
one in eight (13.2%; n=34) reported having never experienced a planned pregnancy. One third 
(30.6%; n=80) had experienced an unplanned pregnancy while using some form of birth control. 
Oral contraceptive pills (49.3%; n=68) were cited most often as the method of contraception 
being used when the pregnancy occurred.  
Women were asked to report on their current contraception status and to indicate which 
methods were being used at the time of the survey. Only methods selected by ten or more women 
were included for analysis. Due to high failure rates, contraception use did not include the 
following methods: withdrawal, douching, or rhythm methods. Slightly more than a third of the 
women (34%; n=90) reported surgical sterilization as their current form of contraception. Among 
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the remaining participants, 27.2% (n=72) reported currently using contraception, 26% (n=69) 
reported no current contraceptive use, and 12.8% (n=31) were currently pregnant at the time of 
survey. Among the women not currently pregnant, not surgically sterilized, and not actively 
trying to get pregnant (n=72), 9.6% (n=16) reported using oral contraceptive pills, 7.8% (n=13) 
reported using Depo Provera, and 7.2% (n=12) reported using condoms as their current 
contraceptive method of choice. The majority of women reported their current form of 
contraception as hysterectomy/BTL (53.9%; n=90). Among the remaining women using 
contraception, few utilized a LARC as their current method of contraception – Implant (7.2%; 
n=12) and IUD (6.6; n=11). 
Birth control methods used in the past five years were also examined. Similar to current 
form of contraception, only methods selected by ten or more women were used in the analysis. 
The number of contraception methods used in the past five years ranged from 1 to 10 (mean = 
1.7). Condoms were identified as the most common form of contraception used in the past five 
years (27.1%; n=71), followed by hysterectomy/BTL (26%; n=68), oral contraceptive pills 
(24%; n=63), and Depo Provera (22.1%; n=58). Similar to the low rate of LARCs used as a 
current method of contraception, few women reported using LARCs over the past five years 
when compared to other methods – IUD (10.3%; n=27) and Implant (9.5%; n=25). 
Participants’ responses regarding reasons for not using contraception in the past year and 
reasons for missing or not making an appointment for birth control were also evaluated. The 
most cited reason for not using birth control was due to having undergone a BTL and/or 
hysterectomy (29%; n=76), or because they were pregnant (29%; n=76). Fewer women reported 
not using contraception for the following reasons: it is okay if they got pregnant (8.4%; n=22), 
did not think you need to (8%; n=21), difficult to take or have available (6.5%; n=17), and 
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missed medical appointment so no prescription (6.5%; n=17). The more frequent reasons for 
missing or not making an appointment for birth control included: surgical sterilization (28.2%; 
n=74), forgot (12.6%; n=33), and overslept (4.2%; n=11). Less than a quarter (16.4%; n=43) 
kept appointment with a healthcare provider in the past year. Table 5 provides a full report of the 
participants’ reproductive health outcomes and behaviors characteristics.  
Reproductive Knowledge and Attitudes 
The participants were asked a variety of questions designed to evaluate their knowledge 
and attitudes towards contraception. Contraceptive knowledge was calculated through 26 
true/false questions. The women’s score was based on the total number of questions answered 
correctly (See Table 2). The percent of true-false knowledge questions answered correctly 
ranged from 0% to 89%, with a mean score of 52.6%. The women, on average, answered fewer 
than half (45.5%; n=254) of the six true/false knowledge questions specific to LARCs correctly. 
Despite low levels of contraception knowledge, two thirds of women (60.7%; n=159) agreed that 
it was important to avoid pregnancy. 
An additional subset of four questions assessed the women’s understanding of perinatal 
risk posed by opioids, specifically NAS risk and concern (Table 2). Higher levels of agreement 
indicated greater perceived risk of NAS. Among this sample, there was a high level of 
appreciation for the perinatal risk posed by opioid use (mean = 1.75) — equivalent to selecting 
“strongly agree” or “agree” for each of the four questions assessing women’s knowledge of 
perinatal risk posed by opioids. Table 6 provides a full report of the participants’ reproductive 
knowledge and attitudes. 
Current Contraception Status Group Differences 
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Birth control use and its necessity were used to categorize the women in relation to 
susceptibility for unplanned pregnancy while enrolled at Rapha Centre for treatment of OUD. 
The first category included those who had undergone surgical sterilization (e.g. hysterectomy 
and/or BTL). The second category included women who reported current birth control use (e.g. 
condoms, oral contraceptive pills, Depo Provera, the NuVa ring, IUD, a diaphragm, implant, 
and/or partner had a vasectomy). The third category included women who were at risk for 
unplanned pregnancy by not using contraception, or if they listed an alternative less reliable 
method (e.g. spermicides, rhythm method, douching, none – currently trying to get pregnant, 
none - do not wish to get pregnant, and none – do not use birth control). A final category was 
created specifically for those currently pregnant at the time of the survey. Table 6 displays group 
differences between previously published significant variables in East Tennessee and three 
categories of contraceptive use — BTL (nmax=90), using contraception (nmax=72), and not using 
contraception (nmax=69). Table 7 specifically includes those who were currently pregnant at the 
time of the survey (nmax=31).  
Group differences regarding sociodemographic characteristics were not assessed due to 
previously published insignificant findings in East Tennessee (Meschke et al., 2018). Group 
differences were evaluated for depressed mood; however, the evidence was insufficient to make 
a conclusion regarding contraception group differences. Initiation of opioids occurred later in life 
for the hysterectomy/BTL group compared to groups not using contraception or those currently 
pregnant. However, women who reported having undergone a BTL/hysterectomy and those not 
using contraception reported a greater number of years since initiating opioid use than women 
using contraception and currently pregnant women. Group differences were not evaluated for the 
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remaining health status and substance use measures due to previously published insignificant 
findings in East Tennessee (Meschke et al., 2018).  
For reproductive health, women were asked if it was important to avoid pregnancy. 
Evidence to support group differences was significant between women having undergone 
BTL/hysterectomy and using contraception. However, the evidence was insufficient to make any 
conclusion that would include the women not using contraception. In addition, no conclusion 
was made regarding significant group differences between the four contraception groups and the 
number of pregnancies or percent of pregnancies that occurred while using birth control.  
Nearly all women agreed that pregnant women should not use painkillers, which made it 
difficult to distinguish if there was any significant difference between contraception groups. 
When evaluating group differences in the percentage of questions on LARCs answered correctly, 
a significant difference was found between the women using contraception and women who 
reported having a hysterectomy/BTL. Women using contraception indicated higher mean levels 
of LARC knowledge than those belonging to the hysterectomy/BTL group. The remaining 
knowledge and attitude measures were not evaluated for group differences due to insignificant 
findings previously published in East Tennessee (Meschke et al., 2018). 
Discussion 
This study provides a comprehensive description of women, ages 18-45, enrolled in MAT 
across Middle Tennessee in 2018. The findings from this study expand upon previously 
published work examining reproductive health knowledge, attitudes, and behaviors among 
women enrolled in MAT for OUD in East Tennessee (Meschke et al., 2018). Together, these 
findings not only provide descriptive data on the women enrolled in MAT across 42 counties in 
both Middle and East Tennessee, but also may provide insight into the factors impacting 
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contraception utilization to avoid unintended pregnancy. Both studies utilized the Theoretical 
Framework of Factors Affecting Contraceptive Use and Avoiding Unintended Pregnancy to 
describe the samples’ past behavior and sociodemographic characteristics, and to report on the 
subjective and objective knowledge of contraception and attitudes of contraception. 
Theoretically, each of the constructs being evaluated predict the utility of contraception to avoid 
unintended pregnancy (behavior) (Ajzen, 1991; Hanson et al., 2014; Montano & Kaspryzyk, 
2015).  
Two questions within the survey were designed to capture unintended pregnancy rates 
among women in the sample. First, women selected yes or no when asked if they had ever 
experienced an unintended pregnancy. Among women in this sample, 43.9% (n=115) indicated 
they had experienced an unplanned pregnancy. Second, women were asked to provide the total 
number of pregnancies and total number of planned pregnancies they had experienced. To 
calculate the total number of pregnancies classified as unplanned or unintended, the number of 
planned pregnancies was subtracted from the total number of pregnancies. A significant 
discrepancy was found between the number of women reporting to have experienced an 
unplanned or unintended pregnancy and the number of unplanned or unintended pregnancies 
determined through calculation. This calculation revealed the number of women having 
experienced at least one unintended pregnancy in their lifetime was nearly double (n=219; 
83.6%) the rates found in the initial yes/no question. Although the calculated rate of unplanned 
pregnancy among women in Middle Tennessee is consistent with the rates among women with 
OUD in East Tennessee, these rates are nearly twice that of the general population in Tennessee 
and nationally (Guttmacher Institute, 2017; Guttmacher Institute, 2019; Meschke et al., 2018). 
However, when compared to unintended pregnancy rates among women with SUD, these 
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findings are consistent to those published in the literature (Black & Day, 2016; Drescher-Burke, 
2014; Guttmacher Institute, 2019; Heil et al., 2011; Robinowitz et al., 2016; Wellings et al., 
2013).  
Socioeconomic Barriers 
The sociodemographic and reproductive health characteristics of women in Middle 
Tennessee accompanied by the high rates of unintended pregnancy is concerning evidence. 
Consistent with the literature, many women indicated they faced a variety of physical and 
emotional challenges including poverty, low education, and histories of physical and sexual 
abuse (Black & Day, 2016; Heil et al., 2011; Morse et al., 2017). While each of these 
characteristics are potential risk factors for experiencing an unintentional pregnancy and 
suggestive of a woman’s health and status, they may not accurately capture women’s experiences 
or circumstances preceding the pregnancy (Black & Day, 2016; Heil et al., 2011; Guttmacher 
Institute, 2019, Morse et al., 2017).  
Women living in poverty have particularly high risk for both addiction and unintended 
pregnancy (Finer & Zolna, 2016; National Institute on Drug Abuse, 2017). Evidence of poverty 
was evident among both samples of women in Middle and East Tennessee receiving MAT for 
OUD. Two thirds (62.2%) of women sampled indicated an annual household income of less than 
$20,000. Likewise, over two-thirds indicated difficulties paying rent, mortgage, or utilities in the 
past year. Although unintended pregnancy rates tend to be highest among low-income women, 
socioeconomic factors were not cited as a primary contributor for not using contraception to 
avoid unintended pregnancy. Further, more women cited socioeconomic factors as a primary 
reason for not using contraception to avoid unintended pregnancy in East Tennessee than in 
Middle Tennessee (Meschke et al., 2018). This difference may be associated with more women 
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in Middle Tennessee being covered by public or private health insurance than those in East 
Tennessee. 
Increasing Contraception Knowledge  
Low levels of contraception knowledge were reported in both Middle and East 
Tennessee. Two-thirds of women in Middle Tennessee indicated it was important to avoid 
pregnancy at the time of the survey; however, most reported low levels of contraception 
knowledge. Accompanying poor knowledge, women cited various reasons for not using birth 
control including: did not think you need to (n=22), method is difficult to remember to take or 
have available (n=18), missed appointments (n=17), only occasionally have sex (n=17), and 
safety concerns (n=16). Based on these responses, further investigation into the women’s self-
efficacy and decision-making processes may be warranted. Likewise, exploring strategies to 
improve contraception knowledge may be useful to improve the uptake of more reliable forms of 
contraception to avoid unplanned pregnancy. 
Of the participating women, 30.6% (n=80) reported at least one pregnancy while using 
birth control; most commonly cited methods of use were oral contraceptive pills, condoms, or 
Depo-Provera. These failure rates in addition to the low levels of LARC knowledge highlight an 
educational opportunity for this population. Using a standardized script explaining LARC 
methods to women, while simultaneously offering same-day access to LARCs at reduced or no 
cost to women, The CHOICE Project showed significant improvements in LARC uptake among 
women at risk for unintended pregnancy (Secura et al., 2010). Piloting projects similar to the 
CHOICE Project at treatment facilities may be an effective way to improve access to 
reproductive health services for women receiving MAT. Likewise, these projects provide women 
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the opportunity to be counseled on various contraceptive methods to enhance their reproductive 
autonomy by selecting the method that best meets their reproductive health needs. 
Lastly, because our sample contained a large number of women who had undergone a 
surgical sterilization, ecological investigations and explorations of decision-making factors 
among women who had undergone a BTL/hysterectomy enrolled in MAT are warranted to 
improve understanding of their reproductive health needs. One third (34%) of the women in our 
study reported having had surgical sterilization (i.e., BTL/hysterectomy). The prevalence of BTL 
in this study was consistent with rates reported in other studies of women with OUD, including 
those in East Tennessee (36.9%). However, sterilization rates in this sample far exceeded the 
estimate for the general US population. From 2013 to 2015, approximately 22% of women in the 
United States, aged 15-44, had undergone surgical sterilization (Kaiser Family Foundation, 
2018). One could speculate that these women have already obtained the goal of having children; 
however, additional research on the decision-making strategies of women who have undergone a 
BTL/hysterectomy could help achieve more effective support for women considering surgical 
sterilization. 
Initiatives Promoting Contraception Access and Utilization 
Although Tennessee opted out of the ACA Medicaid expansion, the state’s public 
insurance TennCare has prioritized improving access to reliable contraception for women with 
OUD. One of TennCare’s strategies specifically aims to reduce barriers to LARC access 
(TennCare, 2018). Additional measures designed to improve access and to increase uptake of 
LARCs among women with OUD receiving MAT include the expansion of Tennessee Medicaid 
reimbursement for immediate post-partum LARC insertion (i.e. IUD or implant) (ACOG, 
2017b). The purpose of the expansion was to reduce barriers and improve access to LARCs for 
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women with OUD receiving MAT by improving reimbursement for healthcare providers 
(ACOG, 2017b). Additional research is needed to make a conclusion on the program’s success. 
On a national level, The Substance Abuse and Mental Health Service Administration 
(SAMSHA) recently revised their Opioid Treatment Program (OTP) Guidelines. The guidelines 
recommend that OTPs provide reproductive health education for all patients and, when needed, 
make appropriate referrals for contraceptive services (SAMSHA, 2015). These recommendations 
stress the importance of enhancing reproductive health education and services for women 
enrolled in MAT. If an OTP is unable to integrate reproductive health services into their existing 
treatment program, SAMSHA encourages OTPs collaboration with local health care providers, 
local public health departments, or community health centers as a strategy to meet the 
recommendation of improving access to reproductive health services for the women being served 
(SAMSHA, 2015). Expanding access and treatment programs to include family planning 
services may help reduce financial and knowledge barriers related to effective contraception.  
Implications for Practice 
This study provides insight on the barriers and facilitating factors that influence a 
woman’s decision to utilize contraception. The findings from this study may be helpful in 
exploring ways to improve the uptake of more reliable forms of contraception among women 
with OUD not using contraception or who are using less reliable methods. By increasing 
women’s knowledge of various contraceptive methods and reducing financial barriers, studies 
report women are more likely to choose a significantly more reliable method of contraception 
such as a LARC (Black & Day, 2016; Secura et al., 2010). More specifically, over 70% of 
women chose a LARC method after contraceptive counseling was provided and financial barriers 
were reduced (Black & Day, 2016; Secura et al., 2010).  
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Successful SUD treatment programs clearly communicate the benefits of effective 
contraception to women, while also offering same day services with skilled providers to reduce 
barriers to access (Black & Day, 2016). Therefore, the findings from this study could be used to 
inform treatment programs of the benefits associated with integrating reproductive health 
services into treatment programs. For treatment programs that have not integrated reproductive 
health services, collaborations with local health departments or community health centers may 
enhance the accessibility of comprehensive family planning services, reduce costs, and improve 
uptake of reliable contraceptive methods. If reproductive health services are readily available for 
women receiving MAT for OUD, not only may the risk of unplanned pregnancies and substance-
exposed pregnancies be reduced, but the quality of life for the women in treatment programs may 
also be improved by facilitating self-efficacy by planning for the family size of their choice 
(Black & Day, 2016; Heil et al., 2011; Heil et al., 2012; Robinowitz et al.,2016; Terplan et al., 
2015).  
Strengths and Limitations 
 The study provides unique and comprehensive insight into the characteristics and patterns 
of contraception use of women enrolled in MAT for OUD across Middle Tennessee. These data 
provide an extension to the previously published findings in East Tennessee. Despite this study’s 
contributions of gaining a better understanding of the barriers and facilitators impacting 
contraception use among women receiving MAT across Tennessee, the individual and combined 
results must be interpreted and used cautiously.  
The first limitation to this study is the survey used had not been previously validated. 
Using a validated tool would have improved the validity and reliability of this study. Second, this 
replication study was designed to determine whether or not the reported barriers and facilitators 
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of contraception use among women enrolled in MAT in East Tennessee could be generalized to 
women currently enrolled in MAT in Middle Tennessee. Since regional differences were found, 
generalizability cannot be assumed. Likewise, it is unknown whether findings from either study 
would adequately describe women receiving MAT in Western Tennessee or other surrounding 
states. Additional research in regions not described in either study is needed to obtain a more 
complete picture of the reproductive health challenges experienced by women receiving MAT in 
Tennessee. Third, since the women completed the survey independently and no assessment of 
the women’s baseline health literacy was performed, the results of the survey may not fully 
represent the population. Response errors may have been limited if the survey was administered 
to the women with assistance.  
There are several strengths to this study. First, this study will contribute to the limited 
body of evidence published on preventing unintended or unplanned pregnancy among women 
receiving MAT for OUD. Next, this study contained a large sample size and high response rate. 
Compared to East Tennessee, few women declined to complete the survey. This study’s higher 
response rates may be attributed to women being asked to independently complete the survey. 
Since the women completed the survey independently, researcher bias was not considered a 
limitation in this study. The risk of bias may have increased had the survey been administered by 
the researcher. Lastly, the risk of data input errors was reduced due to the primary investigator 
independently transcribing the data from the original paper copy into Qualtrics. To ensure no 
errors were made during the transcription process, the primary investigator performed an audit 
on 20% of the transcribed surveys.  
Conclusion 
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This study, an extension of a previously published study that provided a comprehensive 
description of women aged 18–45 enrolled in MAT in East Tennessee in 2015, support those 
findings while also contributing to the limited body of evidence available regarding barriers and 
facilitating factors to contraception use to avoid unintended pregnancy among women enrolled in 
MAT. Because women receiving MAT for OUD experience a number of barriers accessing 
contraception services, treatment programs are encouraged to meet the needs of substance-using 
women by improving the accessibility to reproductive health services. Improved access to high-
quality, integrated, reproductive health care that utilizes a multidisciplinary approach for women 
with OUD is needed due to the co-occurrence of OUD with multiple socioeconomical, physical, 
and emotional challenges. Utilizing a multidisciplinary woman-centered approach towards 
family planning not only is cognizant of historical harms or trauma and current disparities 
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Figure 1. Theoretical Framework of Factors Affecting Contraceptive Use and Avoiding 
Unintended Pregnancy adaptated from The fog zone: How misperceptions, magical 
thinking, and ambivalence put young adults at risk for unplanned pregnancy, by K. Kaye, K. 
Suellentrop & C. Beck, 2009, Retrieved from http://www.thenationalcampaign.org/fogzone/ 
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Figure 3. The government makes certain that BC is safe before they come onto the market 
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Figure 5. Will get pregnant regardless of BC use. 
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Figure 7. Using BC is morally wrong. 
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Table 1: Survey questions aligning with theoretical constructs & measures used in data 
analysis 
Theory Constructs Survey Questions) 
Past Behavior  General health 
 Depressed mood (Table 2) 
 Ever had nonconsensual sex 
 Ever physically abused 
 Physical abuse by romantic partner 
 Age of first opioid 
 Years since first opioid 
 First time in MAT 
 Cigarette use 
 Marijuana use 
 Number of pregnancies 
 Number of pregnancies while on birth control 
Socio-demographics  Age 
 Zip-code 
 Ethnicity 
 Marital status 
 Education level 
 Employment status 
 Insurance coverage 
 Household income 
 Number of persons living in household 
 Challenges paying rent/move in with family  
Exposure to Information  Regular women’s health provider 
Knowledge, Attitudes, & Beliefs  Percent answered correctly (T/F) (Table 2) 
Evaluation of Consequences  NAS risk (Table 2) 
 Women enrolled in MAT should be required by law to 
use long lasting birth control. 
Self-efficacy  Important to avoid pregnancy 
 Fate determines pregnancy 
 Partner determines use of birth control 
Behavior: 
Contraception Use 
 Not using birth control 
 Current birth control use 
 Tubal ligation 
Behavior: 
Effective avoidance of unplanned 
pregnancy 
 Percent unplanned pregnancy 
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Table 2 – Calculated measures 
Measure Survey Questions Scale 
NAS Risk  
(mean) 
 Suboxone use during pregnancy can affect the fetus 
 Taking prescription painkillers during pregnancy can affect 
the fetus. 
 Prescription painkillers can create challenges in pregnancy 
 Community members are concerned about women using 
painkillers during pregnancy. 











In the past week - how often have you experienced the 
following? 
 You felt depressed 
 You felt that everything you did was an effort 
 You felt hopeful about the future (reversed) 
 You were happy (reversed) 
1. Rarely or  
not at all 
2. Some of  
the time 
3. Often 






 It is okay to use the same condom more than once. 
 Condoms have an expiration date. 
 When putting on a condom it is important to leave a space at 
the tip. 
 It is okay to use petroleum jelly or Vaseline as a lubricant 
when using latex condoms. 
 When using a condom, it is important for the man to pull out 
right after ejaculation? 
 Wearing two latex condoms will provide extra protection. 
 Birth control pills are effective even if a woman misses taking 
them for two or three days in a row. 
 Women should “take a break” from the pill every couple of 
years. 
 If a woman is having side effects with one kind of pill, 
switching to another type or brand might help. 
 Birth control pills reduce the chances that women will get 
certain types of cancer. 
 After a woman stops taking birth control, she is unable to get 
pregnant for at least two months. 
 In order to get the birth control pill, a woman must have a 
pelvic exam. 
 A young woman can use an IUD, even if she has never had a 
child. 
 Woman who use IUDs cannot use tampons. 
 To obtain an IUD, a woman must undergo a surgery. 
 An IUD cannot be felt by a woman’s partner during sex. 
 IUDs can move around in a woman’s body 
True or False 
0. Wrong 
Answer 
1. Right  
Answer 
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 Women using the birth control shot, Depo-Provera, must get 
an injection every three months. 
 Even if a woman is late getting her birth control shot, she is 
still protected from pregnancy for at least 3 months. 
 Women using the vaginal ring, or Nuva Ring, must have it 
inserted by a doctor or health care provider every month. 
 Long-acting methods like the implant or IUD cannot be 
removed early, even if a woman changes her mind about 
wanting to get pregnant. 
 After giving birth, a woman can get pregnant even before she 
has her first period. 
 Douching (washing the vagina) after sex can prevent 
pregnancy. 
 A woman who is still breast feeding cannot get pregnant. 
 Pregnancy is much less likely to occur if a couple has sex 
standing up. 
 The only way to completely prevent pregnancy is by not 
having sex. 
 During a woman’s monthly cycle, there are certain days when 
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Table 3 – Sociodemographic characteristics (n = 262) 
 n (%) / mean  SD 

























< High school 























$0 - $10,000 
$10,001 - $20,000 
$20,001 - $30,000 




















































































Number of living children 
None 
1 to 3  
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Table 4 – Self-reported health status and drug use (n = 262) 
 n (%) / mean  SD 
Rating general health 

















(range 1-4, n = 257) 
 
 































Source of first opioid 
Own prescription 
Friend 










Mean age of first opioid 





Years since first opioid use 
































Number of intakes for MAT 
Once 
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Table 5 – Reproductive health outcomes, knowledge, attitudes and behaviors (n = 262) 
 n (%) / mean  SD 






















Birth control methods used in past 5 years: Select 
all that apply. 
(items selected by 10 or more women.; range 1- 10) 
 
Condom 
Bilateral tubal ligation (BTL) / hysterectomy 
Oral contraceptive pills 
Depo 
Withdrawal 


















Current birth control use 
Currently pregnant 
Not using birth control 
Using birth control 








Type of current birth control use  Select all that 
apply. 
(items selected by 10 or more women; range 1- 3) 
 
BTL/Hysterectomy 





Intrauterine device (IUD) 
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In the past 12 months, have there been times when 
you have not used birth control because:   
Select all that apply. 
(items selected by 10 or more women; range 1- 6) 
 
Had BTL or hysterectomy 
You were pregnant 
It is okay if you get pregnant 
You don’t think you need to 
Difficult to remember to take or have available 
Missed medical appts, so no Rx 
Only occasionally have sex 
Safety concerns 
Have always used birth control in the past 12 mo’s 
 














Reason for missing or not making an appointment 
for birth control in the past 12 months:  Select all 
that apply. 
(items selected by 10 or more women; range 1- 7) 
 
Had BTL or hysterectomy 
Forgot 
Kept appointment in past 12 mo 

























Number of pregnancies 
Categorical measures 





































Number of pregnancies that were unplanned 














































Ever become pregnant while using birth control 
 
Yes 
No (including never pregnant) 
Not reported 
 
Most cited failed method  
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Table 6 – Reproductive knowledge and attitudes (n = 262) 
 n mean  SD 
Important to avoid pregnancy 
(range 1-5) 
 
249 1.9  1.4 
 
Perceived risk of neonatal abstinence syndrome (NAS) 
 
 Suboxone use during pregnancy can affect the fetus 
 Taking prescription painkillers during pregnancy can affect 
the fetus 
 Prescription painkillers create challenges in pregnancy 
 Community members are concerned about women using 









1.75  1 
 
2.3  1.3 
1.7  1.1 
1.3  0.7 
1.7  0.9 
 
Percent correct on knowledge deficit scale 
(27 items; range 0% - 89%)  
234 52.6  23.8 
 
 
Percent correct on knowledge of intrauterine devices 
(IUDs) 
(6 items; range 0% - 85%) 
 
254  
45.5  16.7 
 
Social support 
(4 items; range 1-5) 
256 1.5  1.0 
 
 
The government makes certain that birth control is safe 
before they come onto the market. (Figure 3) 
(range 1-5) 




Drug companies don’t care if birth control is safe, they 




251 2.6  1.3 
 
 
Will get pregnant regardless of birth control. (Figure 5) 
(range 1-5) 
254 3.3  1.6 
 
 
You can’t stop to use birth control when aroused.  
(Figure 6) 
(range 1-5) 
248 2.2  1. 4 
 
 
Using birth control is morally wrong. (Figure 7) 
(range 1-5) 
 
249 1.6  1.0 
 
 
Men are more responsible with birth control than women. 
(Figure 8) 
(range 1-5) 
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Table 7 – Chi-squared or One-way ANOVA with Bonferroni Post Hoc Test by Current Contraception Status (Maximum n = 256) 






n Chi-square or 
F-Value 
p-value Sig Mean Contrasts 





35.8 ± 5.2 
 
29.8 ± 5.3 
 






Married/Cohabitating:   
35 (54.5) 
 










Child ever in DCS custody?  
22 (25.3) 
 





















Employed fulltime:  
38 (14.4) 
 















66 (97)  
 


























3.4 ± 0.8 
 
3.1 ± 0.9 
 











2.2 ± 0.9 
 
2.0 ± 0.9 
 













































   
Age of first opioid 
 
 
20.9 ± 6.1 
 
19.4 ± 4.3 
 









Yrs since first opioid 
 
 
14.9 ± 5.8 
 
10.5 ± 4.9 
 
























Reproductive Health Outcomes & Behaviors 
# of pregnancies 
 
 
3.6 ± 1.6 
 
3.1 ± 1.6 
 









% unplanned pregnancies 
 
 
34.6 ± 38.2  
 
33.7 ± 36.6 
 








% pregnancies on BC 
 
 
15.2 ± 25.9  
 
10.9 ± 20.2 
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n Chi-square or 
F-Value 
p-value Sig Mean Contrasts 
Reproductive Knowledge and Attitudes 




1.9 ± 1.4 
 
 
1.3 ± 0.9 
 
 

















2.1 ± 1.1 
 
2.3 ± 1.4 
 








Taking Rx painkillers during pregnancy can 
affect the fetus 
 
1.7 ± 1.0 
  
 
1.8 ± 1.2 
 
 











Painkillers create challenges for pregnancy 
 
 
1.3 ± 0.7 
 
 














Community members are concerned about 




























58.9 ± 17.4 
  
 
65.7 ± 15.1 
 
 
















24.4 ± 21.1 
  
 
34.1 ± 21.6 
 
 















4.2 ± 1.2 
 
4.1 ± 1.2 
 








Government makes certain BC is safe 
 
 
3.2 ± 1.2 
 
3.5 ± 1.3 
 






Drug companies don’t care if BC is safe 
 
 
2.4 ± 1.2 
 
2.6 ± 1.4 
 








Will get pregnant regardless of BC use 
 
 
3.2 ± 1.3  
 
3.1 ± 1.5 
 








Can’t stop to use BC when aroused 
 
 
2.3 ± 1.5  
 
2.2 ± 1.5 
 






Using BC is morally wrong 
 
 
1.8 ± 1.2  
 
1.3 ± 0.8 
 












2.1 ± 1.1 
 
1.9 ± 1.0 
 











CONTRACEPTION USE IN MIDDLE TENNESSEE         61 
Table 7 – Chi-squared or One-way ANOVA with Bonferroni Post Hoc Test by Current Contraception and Pregnancy Status  
(Maximum n = 254) 
 
Measure Hysterectomy 
















 Frequency (%) or Mean ± Standard Deviation 




9.3 ± 2.5 
 
8.5 ± 2.6 
 
9.0 ± 2.6 
 









Age of first opioid 
 
 
20.9 ± 6.1 
 
19.4 ± 4.3 
 
18.5 ± 3.6 
 









Years since first opioid 
 
 
14.9 ± 5.8 
 
10.5 ± 4.9 
 
13.5 ± 5.5 
 









 Reproductive Health Outcomes & Behaviors 
# of pregnancies 
 
 
3.6 ± 1.6 
 
3.1 ± 1.6 
 
3.0 ± 1.6 
 









% pregnancies on BC 
 
 
15.2 ± 25.9  
 
10.9 ± 20.2 
 
6.0 ± 16.9 
 









 Reproductive Knowledge and Attitudes 




1.9 ± 1.4 
 
 
1.3 ± 0.9 
 
 















Painkillers create challenges for pregnancy 
 
 
1.3 ± 0.7 
 
 




















24.4 ± 21.1 
  
 
34.1 ± 21.6 
 
 
31.1 ± 24.7 
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Appendix A - Contraception Utilization Survey 
SOCIODEMOGRAPHICS 
 
Q1 Your birthdate: (MM/DD/YYYY): ______________________________ 
 
 
Q2 What is your residential zip code? ____________________________ 
 
 
Q3 What is your county of residence? ____________________________ 
 
 
Q4 Which best describes you? (Select all that apply) 
• American Indian/Alaska Native (1)  
• Asian (2)  
• Black or African American (3)  
• Hispanic/Latino (4)  
• Native Hawaiian/Other Pacific Islander (5)  
• White (6)  
• Other (please specify): (7) _____________
 
 
Q5 What is your marital status? 
• Single (1)  
• Living with romantic partner  
(e.g. boyfriend, girlfriend, or fiancé) (2)  
• Married (3)  
• Separated (4)  
• Divorced (5)  
• Widowed (6) 
 
 
Q6 What is the highest level of education you have finished? 
• Less than high school (1)  
• High school graduate (2)  
• Some college (3)  
• 2-year college graduate (associates degree) (4)  
• 4-year college graduate (bachelor’s degree) (5)  
• Some graduate school (6)  
• Graduate degree (7)  
• Other (please specify): (8) ______________
 
 
Q7 Which best describes your current employment status? (Select all that apply) 
• Full time (1)  
• Part time (2)  
• Temporary (3)  
• Unemployed - looking for employment (4)  
• Unemployed - not looking for employment (5)  
• Student (6)  
• Retired (7)  
• Homemaker (8)  
• Unable to work (9)  
• Other (please specify): (10) _____________
 
 
Q8 Do you have health insurance coverage? 
• Private (e.g. BCBS, United, Cigna, Aetna) (1)  
• Public (e.g. Medicaid, TennCare) (2)  
• No Insurance (3)  
 
 
Q9 What is your household income? 
• $0-$10,000 (1)  
• $10,001-$20,000 (2)  
• $20,001-$30,000 (3)  
• $30,001-$50,000 (4)  
• Over $50,000 (5)  
• Don't Know (6)  
 
Q10 Number of persons living in household? ______________________________ 
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Q11 Have you had any difficulties paying your rent, mortgage, or utilities in the past year? 
• Yes (1)  • No (2) 
 
 
Q12 In the past year, have you moved in with family/friends because you’ve no other choice? 
• Yes (1)  • No (2)  
 
 
Q13 Think about the past week. How often have you experienced the following? 
 Rarely (1) Sometimes(2) Often (3) Most of the time (4) 
You felt depressed. (1)  •  •  •  •  
You felt that everything you did was an effort. (2)  •  •  •  •  
You felt hopeful about the future. (3)  •  •  •  •  
You were happy. (4)  •  •  •  •  
 
 
Q14 Would you say that your general health is...? 
• Excellent (1)  
• Very Good (2)  
• Good (3)  
• Fair (4)  
• Poor (5)  
 
DRUG USE HISTORY & TREATMENT 
Q15 When did you first begin Suboxone treatment? (MM/YYYY): ______________________________ 
 
 
Q16 How many times have you done intake for Suboxone or Methadone treatment?______________ 
 
 
Q17 Have you ever used or done any of the following? (Select all that apply) 
• Sniffed gasoline, glue, or other substances (1)  
• Drugs with needles or shot up (2)  
• Marijuana or hashish (3)  
• Non-medical use of opioids/not as prescribed (4)  
• Cocaine/crack (5)  
• Heroin or other opiates (6)  
• Nonprescription methadone (7)  
• PCP, hallucinogens/psychedelics, LSD, mushrooms (8)  
• Mescaline (9)  
• Methamphetamine, Amphetamines, other uppers (10) 
• Benzodiazepines, barbiturates, other tranquilizers, downers 
(11)  
• Sedatives or hypnotics (12)  
• Inhalants, poppers, rush, whippets (13)  
• Other (please specify): (14) __________________
 
 
Q18 Which drugs best describe your FIRST use of opioids? (Select all that apply) 
• Buprenorphine (1)  
• Codeine (2)  
• Demerol (3)  
• Dilaudid (4)  
• Exalgo (5)  
• Fentanyl (6)  
• Heroin (7)  
• Hydrocodone (8)  
• Lorcet (9)  
• Lortab (10)  
• Methadone (11)  
• Morphine (12)  
• Norco (13)  
• OxyContin (14)  
• Percocet (15)  
• Roxicodone (16)  
• Suboxone (17)  
• Vicodin (18)  
• Other (19) 
(specify): ______
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Q20 How did you take your FIRST opioid? 
• Swallow (1)  
• Sniffing/Snorting (2)  
• Injecting/Shooting up (3)  
• Other: (4)  _________________________ 
 
 
Q21 How did you get your FIRST opioids? 
• A family members prescription (1)  
• Your own prescription (2)  
• A friend who had the drug (3)  
• Street contact sold the drug (4)  
• Other (please specify): (5) 
_____________________
 
Q22 Do you use marijuana? 
• Yes (1)  • No (2)  
 
 
Q23 Do you smoke cigarettes? 
• Yes (1)  • No (2)
 
 
Q24 Do you use smokeless tobacco? 
• Yes (1)  • No (2)  
 
 
Q25 Do you use e-cigarettes? 
• Yes (1)  • No (2)  
 
PREGNANCY & SEXUAL HEALTH HISTORY 
Q26 Last normal menstrual cycle: MM/YYYY (1) ____________________________________________ 
 
 
Q27 Have you been sexually active in the past 12 months? 
• Yes (1)  • No (2) 
 
 
Q28 How many times have you been pregnant? ___________________ 
 
 
Q29 How many of your pregnancies were planned? ___________________ 
 
 
Q30 How many times have you given birth? ___________________ 
 
 
Q31 How many children are living? ___________________ 
 
 
Q32 How many miscarriages have you had? ___________________ 
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Q34 Have any of your children been in Department of Children's Services' (DCS) custody? 
• Yes (1)  • No (2)
 
 
Q35 Have you had vaginal sex without a condom in the last 2 years? 
• Yes (1)  • No (2)  • Unsure (3)  
 
 
Q36 Have you ever had sex without giving your consent? 
• Yes (1)  • No (2)  
 
 
Q37 Has your romantic partner physically abused (hit, kicked, slapped, etc.) you in the past year? 
• Yes (1)  
 
• No (2)  
 
Q38 Has anyone ever physically abused (hit, kicked, slapped, etc.) you in the past year? 
• Yes (1)  • No (2)  
 
BIRTH CONTROL 
Q39 Have you ever visited a physician or women's health care clinic for birth control? 
• Yes (1)  • No (2)  
 
 
Q40 Do you use Unity Health Care for your gynecological visits? 
• Yes (1)  
• No (2)  




Q41 Do you currently use birth control? 
• Yes (1) • No (2)  • No, currently pregnant (3) 
 
 
Q42 What is your current birth control use?  Check all that apply, may choose more than one. 
• Currently pregnant (1)  
• Condoms (2)  
• Oral contraceptive (pills) (3)  
• Emergency birth control or "Plan B" (4)  
• Patch (5)  
• Depo (injection) (6)  
• NuVa ring (ring) (7)  
• Withdrawal (pulling out) (8)  
• Intrauterine Device (IUD) (9)  
• Spermicides (foam, jelly, or cream) (10)  
• Diaphragm (11)  
• Rhythm method/Natural Family Planning (12)  
• Implant (13)  
• Vaginal douching (14)  
• None - currently trying to get pregnant (15)  
• None - do not wish to get pregnant (16)  
• None - physically unable to become pregnant (17)  
• None - partner had vasectomy (18)  
• None - tubes tied or had hysterectomy (19)  
• None - do not use birth control (20)  
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Q43 Which types of birth control have you used within the past 5 years? (Select all that apply) 
• Condoms (1)  
• Oral contraceptive (pills) (2)  
• Emergency birth control or "Plan B" (3)  
• Patch (4)  
• Depo (injection) (5)  
• NuVa ring (ring) (6)  
• Withdrawal (pulling out) (7)  
• Intrauterine Device (IUD) (8)  
• Spermicides (foam, jelly, or cream) (9)  
• Diaphragm (10)  
• Rhythm method/Natural Family Planning (11)  
• Implant (12)  
• Vaginal douching (13)  
• None - currently trying to get pregnant (14)  
• None - do not wish to get pregnant (15)  
• None - physically unable to become pregnant (16)  
• None - partner had vasectomy (17)  
• None - tubes tied or had hysterectomy (18)  
• None - do not use birth control (19)  
• Other (please specify): (20) ___________
 
Q44 In the past year, have there been times when you haven’t used birth control because: (Select all that apply) 
• You were pregnant (1)  
• It is okay if you get pregnant (2)  
• You do not think you need to (3)  
• Missed medical appointments so no prescription (4)  
• Expensive (5)  
• Difficult to remember to take or have available (6)  
• Did not like the birth control you were using (7)  
• Only occasionally have sex (8)  
• Partner did not want you to use birth control (9)  
• Safety concerns about birth control (10)  
• In menopause (11)  
• Did not have sex with a man (12)  
• You do not have a medical provider (13)  
• You’ve always used birth control in the past 12 
months.(14)  
• Partner had vasectomy (15)  
• Had tubes tied or had hysterectomy (16)  
• No insurance (17)  
• Other (please specify): (18)___________________
 
Q45 In the past year, have you missed/not made an appointment for birth control because (Select all that apply): 
• Forgot (1)  
• Overslept (2)  
• Sick (3)  
• Bad weather (4)  
• Afraid of bad news (5)  
• Had to take care of someone (6)  
• Afraid of pelvic exam (7)  
• Feel violated by pelvic exam (8)  
• Don't like clinic (9)  
• Don't like doctor/nurse practitioner (10)  
• Did not choose doctor/nurse practitioner (11)  
• Transportation (12)  
• Cost (13)  
• Childcare (14)  
• Don't know how to cancel appointment (15)  
• Don't know where to go (16)  
• Prescription necessary (17)  
• Inconvenient (18)  
• Doctor's hours are not convenient (19)  
• Medical person asks uncomfortable questions (20)  
• Exam is uncomfortable (21)  
• Can't get off work or school (22)  
• You’ve never missed an appointment (23)  
• Had tubes tied and/or hysterectomy (24)  
• Met with doctor as scheduled in the past 12 mo. (25)  
• Partner had a vasectomy (26)  
• No insurance (27) • Other (please specify) (28) ________________
 













Q47 What type(s) of birth control were you using? (Select all that apply) 
• Condoms (1)  
• Oral Contraceptive (pills) (2)  
• Patch (3)  
• Depo (injection) (4)  
• NuVa ring (ring) (5)  
• Withdrawal (pulling out) (6)  
• Intrauterine Device (IUD) (7)  
• Spermicides (foam, jelly, cream) (8)  
• Diaphragm (9)  
• Rhythm method/Natural Family 
Planning (10)  
• Implant (11)  
• Vaginal douching (12)  
• None, partner had vasectomy (13)  
• None, have tubes tied or had 
hysterectomy (14)  
• None (15)  
• Other (please specify): (16) 
___________________
 
KNOWLEDGE & MISCONCEPTIONS 
Q48 Please answer the following. 
 








Some people are unable to become pregnant, even if they want to. 
Do you believe that you are infertile or will have difficulty getting 
pregnant when you want to? (1)  
•  •  •  •  
 
 












You are comfortable discussing birth control 
with your doctor. (1)  
•  •  •  •  •  
You are comfortable discussing birth control 
with your partner. (2)  
•  •  •  •  •  
Your partner is supportive of your use of birth 
control. (3)  
•  •  •  •  •  
Your friends support the use of birth control. (4)  •  •  •  •  •  


































Whether you use birth control or not, when it’s 
your time to get pregnant, it will happen. (1)  
•  •  •  •  •  
You can't stop to use birth control when aroused. 
(2)  
•  •  •  •  •  
Drug companies don't care if birth control is safe, 
they want people to use it so they can make 
money.(3)  
•  •  •  •  •  
The government ensures that birth control 
methods are safe before they come onto the 
market. (4)  
•  •  •  •  •  
Using birth control is morally wrong.(5)  •  •  •  •  •  
 
 












You have all the information you need to avoid 
an unplanned pregnancy. (1)  
•  •  •  •  •  
You know where to obtain birth control. (2)  •  •  •  •  •  
Women enrolled in addiction treatment should 
be required by law to use long-lasting birth 
control (e.g. Depo or IUD). (3)  
•  •  •  •  •  
Men and women are equally responsible for 
birth control use. (4)  
•  •  •  •  •  
Men are more responsible in using birth control 
than women.(5)  
•  •  •  •  •  
 
 












Your partner(s) will not let you use birth control. (1)  •  •  •  •  •  
Suboxone use during pregnancy can affect the fetus. (2)  •  •  •  •  •  
Taking prescription painkillers during pregnancy can 
affect the fetus. (3)  
•  •  •  •  •  
Community members are concerned about women 
using painkillers during pregnancy. (4)  













False (2) I don't know (3) 
It is okay to use the same condom more than once. (1)  •  •  •  
Condoms have an expiration date. (2)  •  •  •  
When using a condom, it is important to leave space at the tip. (3)  •  •  •  
It is okay to use petroleum jelly or Vaseline as a lubricant when using latex 
condoms. (4)  
•  •  •  
When using a condom, it is important for the man to pull out right after ejaculation. 
(5)  
•  •  •  
 
 
Q54 For the following, please state whether you think the statement is TRUE or FALSE. 
 True (1) False (2) I don't know (3) 
Wearing two latex condoms will provide extra protection. (1)  •  •  •  
Birth control pills are effective even if a woman misses them for two or three days 
in a row. (2)  
•  •  •  
Women should "take a break" from the pill every couple of years. (3)  •  •  •  
If a woman is having side effects with one kind of pill, switching to another type of 
brand might help. (4)  
•  •  •  
Birth control pills reduce the chances of certain types of cancer. (5)  •  •  •  
 
 
Q55 For the following statements, please state whether you think the statement is TRUE or FALSE. 
 True (1) False (2) I don't know (3) 
After a woman stops taking birth control, she is unable to get pregnant  
for at least two months. (1)  
•  •  •  
In order to get birth control, a woman must have a pelvic exam. (2)  •  •  •  
A woman can use an IUD, even if she has never had a child. (3)  •  •  •  
Woman who use IUDs cannot use tampons (4)  •  •  •  
















Q56 For the following statements, please state whether you think the statement is TRUE or FALSE. 
 True (1) False (2) I don't know (3) 
An IUD cannot be felt by a woman's partner during sex. (1)  •  •  •  
IUDs can move around in a woman's body (2)  •  •  •  
Women using the birth control shot, must get an injection every 3 months. (3)  •  •  •  
Women using a vaginal ring, or Nuva Ring, must have it inserted by a doctor or 
health care provider every month. (4)  
•  •  •  
 
Q57 For the following statements, please state whether you think the statement is TRUE or FALSE. 
 True (1) False (2) I don't know (3) 
Long-acting methods like the implant or IUD cannot be removed early, even if a 
woman changes her mind about wanting to get pregnant. (1)  
•  •  •  
After giving birth, a woman can get pregnant even before she has her first period. 
(2)  
•  •  •  
Douching (washing the vagina) after sex can prevent pregnancy. (3)  •  •  •  
A woman who is still breast feeding cannot get pregnant. (4)  •  •  •  
 
 




False (2) I don't know (3) 
Pregnancy is less likely to occur if a couple has sex standing up. (1)  •  •  •  
The only way to completely prevent pregnancy is by not having sex. (2)  •  •  •  
During a woman's monthly cycle, there are certain days when she is more likely to 
become pregnant if she has sex. (3)  
•  •  •  
Use of opioids or other drugs during pregnancy can create challenges for the 
pregnancy or the unborn child. (4)  
•  •  •  
 
 
 
